Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias

Blood

Volumn 130, Issue 1, 2017, Pages 91-94

  Gibson, Christopher J ^a   Kennedy, James A ^b,c   Nikiforow, Sarah ^a   Kuo, Frank C ^c   Alyea, Edwin P ^a   Ho, Vincent ^a   Ritz, Jerome ^a   Soiffer, Robert ^a   Antin, Joseph H ^a   Lindsley, R Coleman ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3A; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGE DISTRIBUTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL; CYTOPENIA; DONOR; ENGRAFTMENT; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; HUMAN CELL; LETTER; MIDDLE AGED; MUTATIONAL ANALYSIS; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; RISK FACTOR; SOMATIC MUTATION; STEM CELL MOBILIZATION; ADOLESCENT; AGED; ALLOGRAFT; CELL CLONE; DNA SEQUENCE; FEMALE; GENETIC MARKER; GRAFT SURVIVAL; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKOPENIA; MALE; MUTATION; PATHOLOGY; TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALLOGRAFTS; CLONE CELLS; FEMALE; GENETIC MARKERS; GRAFT SURVIVAL; HEMATOLOGIC DISEASES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOPENIA; MALE; MIDDLE AGED; MUTATION; SEQUENCE ANALYSIS, DNA; TISSUE DONORS; YOUNG ADULT;

EID: 85023767599     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2017-01-764951     Document Type: Letter

References (18)

1. Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488-2498.
2. Genovese G, Kähler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26): 2477-2487.
3. Xie M, Lu C, Wang J, et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med. 2014;20(12): 1472-1478.
4. McKerrell T, Park N, Moreno T, et al; Understanding Society Scientific Group. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Reports. 2015;10(8):1239-1245.
5. Kato M, Yamashita T, Suzuki R, et al. Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation. Leukemia. 2016;30(8):1742-1745.
6. Hertenstein B, Hambach L, Bacigalupo A, et al; Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Development of leukemia in donor cells after allogeneic stem cell transplantation–a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2005;90(7):969-975.
7. Gondek LP, Zheng G, Ghiaur G, et al. Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation. Leukemia. 2016;30(9): 1916-1920.
8. Rojek K, Nickels E, Neistadt B, et al. Identifying inherited and acquired genetic factors involved in poor stem cell mobilization and donor-derived malignancy. Biol Blood Marrow Transplant. 2016;22(11):2100-2103.
9. Kluk MJ, Lindsley RC, Aster JC, et al. Validation and implementation of a custom next-generation sequencing clinical assay for hematologic malignancies. J Mol Diagn. 2016;18(4):507-515.
10. Papaemmanuil E, Gerstung M, Malcovati L, et al; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122(22):3616-3627.
11. Walter MJ, Shen D, Ding L, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med. 2012;366(12):1090-1098.
12. Lindsley RC, Mar BG, Mazzola E, et al. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015;125(9):1367-1376.
13. Young AL, Challen GA, Birmann BM, Druley TE. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat Commun. 2016;7:12484.
14. Kollman C, Spellman SR, Zhang M-J, et al. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood. 2016;127(2):260-267.
15. Gibson CJ, Lindsley RC, Tchekmedyian V, et al. Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma [published online ahead of print 9 January 2017]. J Clin Oncol. doi:10.1200/JCO.2016.71.6712.
16. Takahashi K, Wang F, Kantarjian H, et al. Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study. Lancet Oncol. 2017;18(1):100-111.
17. Gillis NK, Ball M, Zhang Q, et al. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study. Lancet Oncol. 2017;18(1):112-121.
18. Fuster JJ, MacLauchlan S, Zuriaga MA, et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017;355(6327):842-847.